• The EPAD site network aims to become the first choice for Industry & Academic sponsored clinical studies in the treatment of Alzheimer’s disease (AD), by streamlining the selection, qualification and set-up of clinical study sites.
• The EPAD LCS will continue its mission of developing a large longitudinal cohort study to ease research participant identification for clinical trials and generate high-quality data to improve disease understanding, defining risk for developing AD and evaluating efficacy.
• The EPAD registers will be a collection of networked local/regional registers aimed predominantly at facilitating discovery of research participants interested in participating in clinical trials for Alzheimer’s disease.
• The EPAD PoC Platform will continue to serve as a collaborative platform for adaptive, multi-arm Proof of Concept (PoC) studies in early Alzheimer’s disease.
• The EPAD Academy will be at the core of EPAD’s scientific activities, by taking a leading role in coordinating data access and analysis, dissemination of results and hosting the early career researcher community
Based on the recommendations from the Geneva General Assembly, EPAD has set up a dedicated change management team tasked with further developing and implementing this model by June 2020. In order to make this transition successful we will need the help and support of all EPADistas over the next six months. So if in the near future you are contacted by someone from the change management team, please respond to their request, join the effort to maintain and build out EPAD so future generations of researchers, drug developers and above all research participants and patients can continue to benefit from the foundation we have build over the last five years. We will keep you posted on our joined efforts in securing EPAD’s future beyond June 2020.
This electronic newsletter will be published quarterly and be accessible via the EPAD website (https://alzheimer.noemi.lu/) and inform the Alzheimer’s community on EPAD’s main achievements, upcoming events as well as allow you to meet the scientists who make it all happen.
We hope you enjoy this issue of the EPAD newsletter! Happy Reading!
Serge Van der Geyten
EPAD Coordinator